NCT06695377View on ClinicalTrials.gov

Thromboembolic Complications in Mild Covid-19 Cases

CompletedOBSERVATIONAL
Enrollment

961

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
COVID 19Thromboembolic and Bleeding ComplicationsThromboembolism, VenousPost COVID-19
Trial Locations (1)

Unknown

Marmara University Medical School, Istanbul

All Listed Sponsors
lead

Marmara University Pendik Training and Research Hospital

OTHER

NCT06695377 - Thromboembolic Complications in Mild Covid-19 Cases | Biotech Hunter | Biotech Hunter